Use of Proximity Ligation to Screen for Inhibitors of Interactions between Vascular Endothelial Growth Factor A and Its Receptors
Author(s) -
Sigrun Gustafsdottir,
Stefan Wennström,
Simon Fredriksson,
Edith Schallmeiner,
Andrew D. Hamilton,
Saı̈d M. Sebti,
Ulf Landegren
Publication year - 2008
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2007.099424
Subject(s) - aptamer , proximity ligation assay , receptor , monoclonal antibody , recombinant dna , chemistry , vascular endothelial growth factor , kinase insert domain receptor , reagent , microbiology and biotechnology , ic50 , biochemistry , pharmacology , antibody , vegf receptors , biology , cancer research , vascular endothelial growth factor a , immunology , in vitro , gene
Improved methods are required to screen drug candidates for their influences on protein interactions. There is also a compelling need for miniaturization of screening assays, with attendant reductions in reagent consumption and assay costs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom